Miriam B. Vos

19.6k total citations · 6 hit papers
130 papers, 8.8k citations indexed

About

Miriam B. Vos is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Miriam B. Vos has authored 130 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Epidemiology, 61 papers in Endocrinology, Diabetes and Metabolism and 30 papers in Physiology. Recurrent topics in Miriam B. Vos's work include Liver Disease Diagnosis and Treatment (90 papers), Diet, Metabolism, and Disease (60 papers) and Diet and metabolism studies (28 papers). Miriam B. Vos is often cited by papers focused on Liver Disease Diagnosis and Treatment (90 papers), Diet, Metabolism, and Disease (60 papers) and Diet and metabolism studies (28 papers). Miriam B. Vos collaborates with scholars based in United States, United Kingdom and Canada. Miriam B. Vos's co-authors include Jean A. Welsh, Elizabeth M. Brunt, Dina Tiniakos, Zobair M. Younossi, Joel E. Lavine, Saul J. Karpen, Andrea J. Sharma, Vincent Wai‐Sun Wong, Barjesh Chander Sharma and Elisabetta Bugianesi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Miriam B. Vos

125 papers receiving 8.6k citations

Hit Papers

Global Perspectives on Nonalcoholic Fatty L... 2010 2026 2015 2020 2018 2010 2016 2022 2016 400 800 1.2k

Peers

Miriam B. Vos
Miriam B. Vos
Citations per year, relative to Miriam B. Vos Miriam B. Vos (= 1×) peers Shira Zelber‐Sagi

Countries citing papers authored by Miriam B. Vos

Since Specialization
Citations

This map shows the geographic impact of Miriam B. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam B. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam B. Vos more than expected).

Fields of papers citing papers by Miriam B. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam B. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam B. Vos. The network helps show where Miriam B. Vos may publish in the future.

Co-authorship network of co-authors of Miriam B. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam B. Vos. A scholar is included among the top collaborators of Miriam B. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam B. Vos. Miriam B. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nichols, L., Cynthia Behling, Mark Fishbein, et al.. (2025). Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition. 82(3). 741–750.
3.
Xanthakos, Stavra A., Samar H. Ibrahim, Kathryn Betts Adams, et al.. (2025). AASLD Practice Statement on the evaluation and management of metabolic dysfunction–associated steatotic liver disease in children. Hepatology. 82(5). 1352–1394. 10 indexed citations
4.
Younossi, Zobair M., Homie Razavi, Michael S. Sherman, et al.. (2025). Addressing the High and Rising Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction‐Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective. Alimentary Pharmacology & Therapeutics. 61(9). 1467–1478. 8 indexed citations
5.
Newton, Kimberly P., Amanda L. Blackford, Cynthia Behling, et al.. (2025). Longitudinal response to standard of care in pediatric metabolic dysfunction–associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes. Hepatology. 82(5). 1198–1210. 3 indexed citations
7.
Vos, Miriam B., et al.. (2023). Special Population. Clinics in Liver Disease. 27(2). 471–482. 2 indexed citations
8.
Accardi, Carolyn Jonas, Dean P. Jones, Ken Liu, et al.. (2023). Metabolome × Microbiome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys. Metabolites. 13(3). 401–401. 2 indexed citations
9.
Wang, Andrew, Amanda L. Blackford, Cynthia Behling, et al.. (2023). Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Hepatology. 79(6). 1381–1392. 12 indexed citations
10.
Westbrook, Adrianna, Jennifer K. Frediani, Mark Griffiths, et al.. (2022). Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant. Clinical Infectious Diseases. 75(7). 1131–1139. 3 indexed citations
11.
Li, Kelvin W., Adina Alazraki, Carine Beysen, et al.. (2021). Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease. Journal of Clinical Investigation. 131(24). 51 indexed citations
12.
Rees, Chris A., Christina A. Rostad, Grace Mantus, et al.. (2021). Altered amino acid profile in patients with SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 118(25). 73 indexed citations
13.
Younossi, Zobair M., Frank Tacke, Marco Arrese, et al.. (2018). Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology. 69(6). 2672–2682. 1358 indexed citations breakdown →
14.
Frediani, Jennifer K., Eric A. Naioti, Miriam B. Vos, et al.. (2018). Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among US adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. Environmental Health and Preventive Medicine. 17(1). 6–6. 1 indexed citations
15.
He, Siran, Ngoc‐Anh Le, Jennifer K. Frediani, et al.. (2017). Cardiometabolic risks vary by weight status in pediatric kidney and liver transplant recipients: A cross‐sectional, single‐center study in the USA. Pediatric Transplantation. 21(6). 5 indexed citations
16.
Barritt, A. Sidney, Norman Gitlin, Samuel Klein, et al.. (2017). Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemporary Clinical Trials. 61. 33–38. 39 indexed citations
17.
Vos, Miriam B., Stephanie H. Abrams, Sarah E. Barlow, et al.. (2016). NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children. Journal of Pediatric Gastroenterology and Nutrition. 64(2). 319–334. 684 indexed citations breakdown →
18.
Nelson, Jennifer, Miriam B. Vos, Stephanie Walsh, Lauren O’Brien, & Jean A. Welsh. (2015). Weight Management-Related Assessment and Counseling by Primary Care Providers in an Area of High Childhood Obesity Prevalence: Current Practices and Areas of Opportunity. Childhood Obesity. 11(2). 194–201. 29 indexed citations
19.
Jin, Ran, Shivani Patel, Xiaoyan Sun, et al.. (2014). Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease. International Journal of Hepatology. 2014. 1–8. 84 indexed citations
20.
Walsh, Stephanie, et al.. (2014). Challenges and Successes of a Multidisciplinary Pediatric Obesity Treatment Program. Nutrition in Clinical Practice. 29(6). 780–785. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026